[Expression of lymphocyte activation markers in patients with gastrointestinal tumors at different stages]
- PMID: 16756013
[Expression of lymphocyte activation markers in patients with gastrointestinal tumors at different stages]
Abstract
Patients with gastrointestinal tumors revealed relatively high levels of activated lymphocytes. CD25 expression at later stages was much higher than at earlier ones (I-II). A relationship between CD25, CD71 and CD95 expression was established for metastatic spread of gastrointestinal tumors as well as a correlation between CD71 and CD98 expression for favorable course. A distinct activation phenotype can be identified for peripheral blood lymphocytes in burgeoning tumor which should be taken into account in prognosis.
Similar articles
-
Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.Folia Histochem Cytobiol. 2011;49(4):593-603. Folia Histochem Cytobiol. 2011. PMID: 22252753
-
Dynamics of circadian fluctuations in serum concentration of cortisol and TNF-alpha soluble receptors in gastrointestinal cancer patients.Oncol Rep. 2001 Jan-Feb;8(1):207-12. doi: 10.3892/or.8.1.207. Oncol Rep. 2001. PMID: 11115600
-
The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.Folia Histochem Cytobiol. 2011;49(4):579-92. Folia Histochem Cytobiol. 2011. PMID: 22252752
-
Diagnosis of follicular lymphoma of the gastrointestinal tract: A better initial diagnostic workup.World J Gastroenterol. 2016 Jan 28;22(4):1674-83. doi: 10.3748/wjg.v22.i4.1674. World J Gastroenterol. 2016. PMID: 26819532 Free PMC article. Review.
-
Use of proteomic patterns to screen for gastrointestinal malignancies.Surgery. 2004 Mar;135(3):243-7. doi: 10.1016/j.surg.2003.08.019. Surgery. 2004. PMID: 14976472 Review. No abstract available.
Cited by
-
CD98 at the crossroads of adaptive immunity and cancer.J Cell Sci. 2012 Mar 15;125(Pt 6):1373-82. doi: 10.1242/jcs.096040. Epub 2012 Apr 12. J Cell Sci. 2012. PMID: 22499670 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Research Materials